Document Type : Original Article
Authors
Department of Dermatology, STDs and Andrology, Faculty of Medicine, Minia University, Egypt
Abstract
Highlights
Conclusion
Acne vulgaris is a disease of the pilosebaceous unit, resulting from the interplay of different factors including; seborrhea, P. acnes coloni-zation, hyperkeratinization of the follicular duct and release of inflammatory mediators. Increased sebum lipogenesis by sebaceous gland is considered the major one involved in the pathophysiology of acne. And conclusion, the present study revealed that adapalene is effective in the treatment of acne vulgaris lesions with minimal downtime.
Keywords
Main Subjects
Introduction
Acne is a chronic inflammatory condition of the pilosebaceous unit(1). It causes non inflam-matory lesions (open and closed comedones), inflammatory lesions (papules, pustules, and nodules), and varying degrees of scarring(2) Its pathophysiology involves three actors, increase sebum production, abnormal follicular keratini-zation and bacterial proliferation in the pilosebaceous unit(3).
The initial acne lesion is the microcomedone, which is microscopic structure. During the course of acne, non-inflammatory lesions form, including closed (whiteheads) and open (blackheads) comedones, followed by inflam-matory lesions that include superficial lesions such as a papules and pustules (≤5mm in diameter) and deep pustules or nodules (4). Acne leads to significant morbidity that is associated with residual scarring and psychological disturbances such as poor self-image, depression, and anxiety, which leads to a negative impact on quality of life. (5)
Treatment of acne vulgaris includes topical and systemic treatments. Topical modalities is useful in mild and moderate acne, as single agent treatment, in combination and also as maintenance therapy, while systemic treatment used in severe acne vulgaris (6). The aim is to evaluate the role of adapalene in treatment of acne valguris
Subjects and Methods
The present study has been conducted on 20 patients with mild to moderate acne vulgaris attending the outpatient clinic of the Depart-ment of Dermatology, STDs and Andrology, Minia University Hospital. All patients were females. The age of patients ranged from 16 to 33 years. They were attending the Dermatology outpatient clinic of Minia University Hospital in the period from January 2019 to June 2020.
All patients were subjected to full history taking, examination, photography and biopsy before and after the treatment The severity of inflammation was graded according to (Barakat et al., 2016)(7) as follows;
Statistical analysis
Data were statistically analyzed using SPSS program. The statistical difference before and after treatment was expressed in p value which was considered significant when it was ˂ 0.05.
Results
We noticed clinical improvement in most of cases which was in the form of decrease the number of non-inflammatory, inflammatory and total acne lesions after 12 weeks of treatment (fig1).
Fig. (1): excellent improvement after the treatment.
There was reduction percentage in the 3 forms of lesion as follows (0%, 63.3%, 55.6%) after the treatment and there was statistically significant difference before and after the treatment (p<0.001).
After Adapalene treatment, the infiltrate score significantly decreased (P value = <0.001).
Fig. (2): showing significant reduction in the inflammatory infiltrate after the treatment.
Discussion
Acne vulgaris is a disease of the pilosebaceous unit, resulting from the interplay of different factors including; seborrhea, P. acnes coloni-zation, hyperkeratinization of the follicular duct and release of inflammatory mediators. Increased sebum lipogenesis by sebaceous gland is considered the major one involved in the pathophysiology of acne (8).
Adapalene (ADP) is a representative of the third retinoids generation and successfully used in first-line acne treatment. ADP binds to retinoic acid nuclear receptors. The comedolytic, anti-
inflammatory, antiproliferative, and immune-modulatory are the known ADP effects. Its safety profile is an advantage over other retinoids (9)
References